AIDS Weekly articles from July 1994

AIDS Weekly archives from July 1994

FDA approves stavudine for HIV.
July 4, 1994... DATELINE: AIDS Therapy The U.S. Food and Drug Administration (FDA) announced the approval of stavudine, or D4T - the fourth drug approved for the treatment of AIDS and HIV infection. Stavudine is an antiviral agent of the nucleoside...

U.S. blood collection centers criticized by news media. (for poor quality control)
July 4, 1994... DATELINE: Blood Safety "The FDA fully expected the number of errors and accidents would increase as blood banks were required to report them to the FDA," Monica Revelle, U.S. Food and Drug Administration (FDA) spokesperson, told AIDS...

Jury says blood screeners must pay. (for AIDS transmission from a transfusion)
July 4, 1994... DATELINE: Legal Issue The group that sets standards for the nation's blood supply was ordered to pay $570,000 to a man who got AIDS from a transfusion. A 67-year-old man's lawsuit was the first successful one of its kind against the...

FDA debates home test for AIDS.
July 4, 1994... DATELINE: Testing The U.S. Food and Drug Administration (FDA) debates a tricky side issue of the AIDS epidemic: should Americans test themselves for the virus at home? Three companies are seeking FDA approval for drugstore sales of...

Japan hotels told to welcome people with AIDS. (X International Conference on AIDS)
July 4, 1994... DATELINE: Controversy The Japanese Health Ministry urged hotels to welcome people with AIDS attending the X International Conference on AIDS in Yokohama in August 1994. About to 1,000 people with AIDS or who carry HIV are expected...

Vitamin A deficiency linked to AIDS transmission.
July 4, 1994... DATELINE: Nutrition Vitamin A deficiency during pregnancy may make an HIV-infected mother more likely to pass the disease on to her baby, researchers working in Malawi and the United States said in a Reuters news report. In a report...

Ethnobotanist seeks new cures. (Paul Alan Cox works with Samoan healers to find cure for AIDS)
July 4, 1994... DATELINE: Research Paul Alan Cox, ethnobotanist, Fulbright scholar and Harvard Ph.D., thought he could spend three months with Samoan healing women and completely absorb their medical wisdom. A decade later, he laughs at his...

Researcher finds way to spot neurodegeneration in HIV-positive patients. (Aukse Bankaitis)
July 4, 1994... DATELINE: Development A graduate student in the University of Cincinnati (UC), Ohio, department of communication sciences and disorders has demonstrated that a common tool of audiologists may be able to identify early signs of...

Heads of state asked to make commitment. (to AIDS prevention in Africa)
July 4, 1994... DATELINE: AIDS Control Dr. Hiroshi Nakajima, Director-General of the World Health Organization (WHO), appealed to the African heads of state meeting in Tunis, June 13-14, 1994, for the summit of the Organization of African Unity (OAU),...

HIV babies home an oasis in midst of turmoil. (House of Mercy in Bangkok, Thailand)
July 4, 1994... DATELINE: International Set amid a lush private tropical jungle in one of Bangkok, Thailand's busiest and most traffic-choked neighborhoods is a wooden house of gleaming teakwood floors, wide screened verandas and fully air-conditioned...

Biopharmaceutics announces HIV pact and test results. (Biopharmaceutics Inc.'s agreement with the Central Research Institute for Chemistry of the Hungarian Academy of Sciences)
July 4, 1994... DATELINE: Testing Biopharmaceutics Inc. (Biopharm) announced that it has entered into a final agreement with the Central Research Institute for Chemistry of the Hungarian Academy of Sciences (CRIC) and has acquired a 50 percent interest...

Researchers survey traditional birth attendants in Rwanda. (for occupational HIV risk)
July 4, 1994... DATELINE: Occupational HIV Risk The risk of occupationally-acquired HIV infection among traditional birth attendants (TBA) in Rwanda was found to be small. While the finding was encouraging to the survey participants, the low risk...

Bisexual men are unlikely to transmit HIV infection to women. (San Francisco)
July 4, 1994... DATELINE: Study San Francisco, California, men who identify themselves as bisexual are unlikely to spread HIV infection to their female partners, according to a University of California, San Francisco (UCSF), study that examined their...

Female condoms in Argentina.
July 4, 1994... DATELINE: International Female condoms are now for sale in Argentina, a country where most men refuse to wear condoms. The product that ended the masculine monopoly on the prevention of sexually-transmitted diseases has been in the...

Official says government losing AIDS battle. (Miguel Angel Calello of the National Program for the Fight Against AIDS, Argentina)
July 4, 1994... DATELINE: Argentina Argentine health officials said the government is losing the battle against AIDS and that at least 25 to 30 people die each month in Buenos Aires hospitals from the disease. "AIDS is not controlled. It's...

Sheffield Medical Technologies obtains exclusive license. (for technology usage of compounds from Harvard Medical School research)
July 4, 1994... DATELINE: Pharmaceutical Update Sheffield Medical Technologies Inc., Houston, Texas, announced that it has received an exclusive option from the President and Fellows of Harvard College to obtain an exclusive worldwide license for...

Intracellular activity of roxithromycin used alone and in association with other drugs against the Mycobacterium avium complex in human macrophages. (Research Report)
July 4, 1994... DATELINE: MAC and Drug Activity. Intracellular Activity of AUTHORS: N. Rastogi 1, V. Labrousse 2 and A. Bryskier 3. 1Institut Pasteur, Tuberculose & Mycobacteries, Guadeloupe, French West Indies; 2Institut Pasteur, Paris, France; and...

Defects in the function of macrophages (M-phi) from HIV+ individuals in host defense against Histoplasma capsulatum (Hc). (Research Report)
July 4, 1994... AUTHORS: S. Chaturvedi, S.L. Newman and P. Frame. University of Cincinnati, Cincinnati, Ohio. According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las...

Synergistic antiretroviral activities of the herb, Prunella vulgaris, with AZT, ddI, and ddC. (zidovudine, didanosine, zalcitabine) (Research Report)
July 4, 1994... AUTHORS: J.F. John, R. Kuk and A. Rosenthal. Robert Wood Johnson Medical School, New Brunswick, New Jersey; and Herbal Research Center, Morganville, New Jersey. According to an abstract submitted by the authors to the 94th Meeting of...

Identification of three distinct HIV-1 subtypes in Brazil based on the protease gene. (Research Report)
July 4, 1994... AUTHORS: L.M. Janini, C.-C. Luo, M. Peralta, M. Schecther, M.L. Kalish, N. Peniazek, N. De La Torre, G. Schochetman, M. Rayfield and D. Peniazek. U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; and Universidade Federal de...

Combination of peptide protease inhibitor and recombinant interferon-alpha A synergistically inhibited acute and chronic HIV-1 infection in vitro. (Research Report)
July 4, 1994... AUTHORS: P.J. Pagano and K.T. Chong. Upjohn Laboratories, Kalamazoo, Michigan. According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada,...

Monoclonal antibodies to the MLV protease active site that crossreact with the HIV protease. (murine leukemia virus) (Research Report)
July 4, 1994... AUTHORS: R.B. Luftig, P. Calkins and H.-Y. Yeh. Louisiana State University, Medical Center, New Orleans, Louisiana. According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held...

Effects of megestrol acetate therapy upon body composition and serum testosterone in patients with AIDS. (Research Report)
July 4, 1994... AUTHORS: E.S. Engelson, A.R. Tierney, F.X. Pi-Sunyer and D.P. Kotler. Columbia University, St. Luke's-Roosevelt Hospital Center, New York, New York. According to an abstract submitted by the authors to a joint meeting of the American...

Alterations in hydration in HIV-infected individuals. (Research Report)
July 4, 1994... AUTHORS: G. Babameto, D.P. Kotler, S. Burastero, J. Wang and R.N. Pierson. Columbia University, St. Luke's -Roosevelt Hospital Center, New York, New York. According to an abstract submitted by the authors to a joint meeting of the...

Application of single frequency bioimpedance analysis for the study of body composition in HIV-infected individuals. (Research Report)
July 4, 1994... AUTHORS: D.P. Kotler, G. Babameto, S. Burastero, J. Wang, and R.N. Pierson. Columbia University, St. Luke's -Roosevelt Hospital Center, New York, New York. According to an abstract submitted by the authors to a joint meeting of the...

Both naive and memory CD4 T-cell subsets become aneric during MAIDS and subset can sustain disease. (murine acquired immunodeficiency virus)(Adapted from the Journal of Immunology, June 1, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Immunology, June 1, 1994;152(11):5548-5556. According to the authors' abstract of an article published in the Journal of Immunology, "Infection of C57BL/6 mice with the LP-BM5 mixture of retroviruses causes a...

A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. (Adapted from the Journal of Virology, June 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Virology, June 1994;68(6):4075-4079. According to the authors' abstract of an article published in the Journal of Virology, "Furin, a subtilisin-like mammalian endoprotease, is thought to be responsible for the...

Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization. (Adapted from the Journal of Virology, June 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Virology, June 1994;68(6):3459-3466. According to the authors' abstract of an article published in the Journal of Virology, "Neutralization of a chimeric human immunodeficiency virus (HIV) type 1, containing the V3...

Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphoctyes. (Adapted from the Journal of Virology, June 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Virology, June 1994;68(6):3888-3895. According to the authors' abstract of an article published in the Journal of Virology, "Human immunodeficiency virus type 1 (HIV-1) can be used to generate recombinant viral...

Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. (Adapted from the Journal of Virology, June 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Virology, June 1994;68(6):3830-3840. According to the authors' abstract of an article published in the Journal of Virology, "The architecture of a retroviral genome presents some unusual features for...

3'-azido-3'-deoxythymidine potently inhibits protein glycosylation - a novel mechanism for AZT cytoxicity. (zidovudine)(Adapted from the Journal of Biological Chemistry, May 20, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Biological Chemistry, May 20, 1994;269(20):14355-14358. According to the authors' abstract of an article published in the Journal of Biological Chemistry, "3' -Azido-3'-deoxythymidine (AZT) is one of the primary...

Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. (Adapted from the Journal of Biological Chemistry, May 13, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Journal of Biological Chemistry, May 13, 1994;269(19):13811-13816. According to the authors' abstract of an article published in the Journal of Biological Chemistry, "The pathogenesis of the human immunodeficiency virus...

Characterization of human immunodeficiency virus type 1 Pr55(gag) membrane association in a cell-free system: requirement for a C-terminal domain. (Adapted from the Proceedings of the National Academy of Sciences of the United States of America, May 10, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, May 10, 1994;91(10):4594-4598. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences of...

Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. (Adapted from the Proceedings of the National Academy of Sciences of the United States of America, May 10, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, May 10, 1994;91(10):4559-4563. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences of...

Disseminated cutaneous cryptococcosis - comparison of clinical manifestations in the pre-AIDS and AIDS eras. (Adapted from the Archives of Internal Medicine, May 9, 1994) (Periodical Report) (Abstract)
July 4, 1994... SOURCE: Archives of Internal Medicine, May 9, 1994;154(9):1032-1034. According to the authors' abstract of an article published in Archives of Internal Medicine, "A review of the literature suggests some differences in the cutaneous...

Japan conference abstracts on CD-ROM for first time. (10th International Conference on AIDS)
July 11, 1994... DATELINE: International As Japan prepares to play host to a tenth world AIDS conference, in the U.S. the staff at CW Henderson, publisher of AIDS Weekly, is preparing to make the conference abstracts available on CD-ROM for the first...

Company announces FDA approval for HIV drug. (Food and Drug Administration; Zerit, stavudine) (Product Announcement)
July 11, 1994... DATELINE: Drug Approval Bristol-Myers Squibb Company announced that it has received U.S. Food and Drug Administration (FDA) clearance to market Zerit (stavudine), a new anti -retroviral agent to treat persons with advanced HIV disease....

Experts to provide state-of-art reviews. (on infectious diseases)
July 11, 1994... DATELINE: Conference Report Changes in healthcare management mean that internists must remain up to date on issues in infectious disease once considered the domain of specialists, says Henry Masur, chief of critical care medicine at the...

HIV-related research intramural program. (clinical trials conducted by the National Institute of Allergy and Infectious Diseases and the Clinical Center)
July 11, 1994... DATELINE: Program The following lists research studies available at the U.S. National Institutes of Health (NIH) on the NIH Campus in Bethesda, Maryland. Studies are conducted by the National Institute of Allergy and Infectious Diseases...

Vitamin A may play critical role in HIV transmission.
July 11, 1994... DATELINE: Nutrition Vitamin A may play a critical role in the transmission of HIV from mother to child. According to researchers at the Johns Hopkins School of Public Health, HIV-infected mothers who were deficient in vitamin A during...

Media reports could hamper AIDS vaccine progress.
July 11, 1994... DATELINE: Controversy According to an article in the Vanderbilt University Medical Center (VUMC) Reporter, Phase I testing of potential AIDS vaccines is continuing even as scientists debate whether the time is right for large-scale...

HIV cases up 60 percent.
July 11, 1994... DATELINE: Status The estimated number of advanced AIDS cases worldwide increased from 2.5 million to 4 million in the past 12 months - a rise of 60 percent, the World Health Organization (WHO) said. Sub-Saharan Africa had the...

Combined intra- and extracellular immunization. (HIV vaccines)
July 11, 1994... DATELINE: HIV Vaccines CD4(+) T cells genetically engineered to produce fragments of a human anti-gp120 antibody not only resist HIV*1 infection but also protect neighboring cells from infection, report Harvard Medical School...

Oral ganciclovir new drug application submitted.
July 11, 1994... DATELINE: Drug Syntex Corporation, Palo Alto, California, said that the company has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) seeking FDA clearance to market an oral formulation of ganciclovir...

Company receives broad U.S. patents for therapies. (Repligen Corp.; cyclocreatine for antitumor and antiviral therapies)
July 11, 1994... DATELINE: Therapy Repligen Corporation, Cambridge, Massachusetts, announced that the United States Patent and Trademark Office has awarded the company two broad patents covering novel uses of AM285 (cyclocreatine) for both antitumor and...

Clinical study with hypericin to begin.
July 11, 1994... DATELINE: Study VIMRx Pharmaceuticals Inc. announced that Johns Hopkins University, Baltimore, Maryland, has obtained both Institutional Review Board approval and become officially site-registered with the U.S. National Institutes of...

Virus inactivation studies required for trials. (Immupath, anti-HIV hyperimmune plasma)
July 11, 1994... DATELINE: Clinical Trials HemaCare Corporation announced that at a meeting between the U.S. Food and Drug Administration (FDA) and company representatives held on June 27, 1994, significant progress was made toward the commencement of...

HIV-positive Kaposi's sarcoma patients needed for trial. (topical retinoid medication LGD1057)
July 11, 1994... DATELINE: Clinical Trial University of California, Los Angeles' (UCLA) Center for AIDS Research and Education (CARE) is seeking HIV -positive subjects with Kaposi's sarcoma (KS) skin lesions to participate in a study involving a topical...

Research program opens retroviral research laboratory. (Tri-Service Military HIV Research Program)
July 11, 1994... DATELINE: Development A ribbon cutting ceremony will take place for a new state-of-the-art retroviral research laboratory on June 29, 1994. The laboratory, which is a part of the U.S. Army-sponsored Tri-Service Military HIV Research...

Reduction of HIV transmission from mothers to newborns. (with AZT treatment)
July 11, 1994... DATELINE: Pregnancy and HIV A new study by researchers at the University of California, Los Angeles (UCLA), School of Medicine show that HIV-positive women who took AZT (zidovudine) during pregnancy and/or delivery had significant...

Dual-use contraception recommended for some. (using one contraceptive for preventing pregnancy, another for preventing sexually transmitted diseases)
July 11, 1994... DATELINE: Contraception Due to the increasing incidence of AIDS, some family planning clinics are recommending that their clients use two contraceptives simultaneously - one to prevent pregnancy and another to prevent sexually...

Quantitation and genetic analyses of HIV-1 in blood monocytes and alveolar macrophages. (Research Report)
July 11, 1994... AUTHORS: K. Nakata, M. Weiden, T. Harkin, D. Ho and W.N. Rom. New York University, Medical Center, New York, New York; and Aaron Diamond AIDS Research Center, New York, New York. According to an abstract submitted by the authors to the...

HIV-1 derived peptides bind to rat lung alveolar epithelial cells and modulate proliferation. (Research Report)
July 11, 1994... AUTHORS: N.M. Kumar, N.H. Rabadi, M.P.N. Nair, S.A. Schwartz and J.S. Lwebua-Mukasa. State University of New York, Medical School, Buffalo, New York. According to an abstract submitted by the authors to the 1994 International...

Use of budesonide in acquired immunodeficiency syndrome (AIDS)-related airway hyperreactivity. (Research Report)
July 11, 1994... AUTHORS: J.L. Reggiani, F. Haas, A. Compagnucci, K. Axen and J. Salazar-Schicchi. Muniz Hospital, University of Buenos Aires, Buenos Aires, Argentina; Hotel-Dieu, Paris, France; and New York University, School of Medicine, New York, New...

Physicians' attitudes regarding treatment and prevention of AIDS-related disseminated Mycobacterium avium complex (MAC) infection. (Research Report)
July 11, 1994... AUTHORS: J.S.G. Montaner, K.J.P. Craib, R. Hogg, P. Phillips, M. O'Shaughnessy and M.T. Schechter. St. Paul's Hospital and University of British Columbia, Vancouver, B.C., Canada. According to an abstract submitted by the authors to the...

Mycobacteria other than tuberculosis. (Research Report)
July 11, 1994... AUTHORS: L. Blumberg. University of the Witwatersrand and SAIMR, Johannesburg, South Africa. According to a plenary abstract presented by the author to the conference entitled Tuberculosis - Towards 2000, held March 13-17, 1994, in...

Tuberculosis and HIV in sub-Saharan Africa - can a good tuberculosis program make a difference? (Research Report)
July 11, 1994... AUTHORS: M.C. Cantwell and N.J. Binkin. U.S. Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, Georgia. According to a plenary abstract presented by the authors to the conference entitled...

Pulmonary disease in sputum smear negative HIV-infected patients from Africa. (Research Report)
July 11, 1994... AUTHORS: J. Murray 1, S. Klempman 1, A.K. Mahomed 2, G. Richards 2, C. Feldman 2 and J. Kallenbach 2. 1National Center for Occupational Health, Johannesburg, South Africa; and 2University of the Witwatersrand, Johannesburg, South Africa. ...

Kaposi's sarcoma, vascular permeability, and scientific integrity. (adapted from JAMA - Journal of the American Medical Association, June 8, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: JAMA - Journal of the American Medical Association, June 8, 1994;271(22):1769-1771. According to the authors' abstract of an article published in JAMA - Journal of the American Medical Association, "On March 13, 1992,...

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. (adapted from Nature, June 2, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Nature, June 2, 1994;369(6479):403-407. According to the authors' abstract of an article published in Nature, "Most asymptomatic individuals infected with HIV-1 have a cytotoxic T-lymphocyte (CTL) response to the virus Gag...

Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies. (adapted from Journal of Clinical Microbiology) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Journal of Clinical Microbiology, June 1994;32(6):1449-1456. According to the authors' abstract of an article published in the Journal of Clinical Microbiology, "An enzyme immunoassay using the purified native gp160 for the...

Mediastinal and hilar lymphadenopathy due to Pneumocystis carinii infection in AIDS patients - CT features. (computed tomography)(adapted from Journal of Computer Assisted Tomography, May-June, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Journal of Computer Assisted Tomography, May -June 1994;18(3):408-411. According to the authors' abstract of an article published in Journal of Computer Assisted Tomography, "Objective: Extrapulmonary involvement by...

Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. (adapted from Virology, June, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Virology, June 1994;201(2):285-293. According to the authors' abstract of an article published in Virology, "We studied the relationship between the rate of disease progression after HIV-1 seroconversion and the level of IgG...

Binding of human immunodeficiency virus type 1 (HIV-1) gp120 to galactosylceramide (GalCer) - relationship to the V3 loop. (adapted from Virology, June, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Virology, June 1994;201(2):206-214. According to the authors' abstract of an article published in Virology, "The primary receptor for the human immunodeficiency virus (HIV) is the CD4 molecule. However, a large body of...

Role of vif during packing of the core of HIV-1. (viral infectivity factor gene)(adapted from Virology, June, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Virology, June 1994;201(2):349-355. According to the authors' abstract of an article published in Virology, "The viral infectivity factor gene vif of human immunodeficiency virus type 1 (HIV-1) has been shown to enhance the...

Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. (adapted from Proceedings of the National Academy of Sciences of the United States of America, May 24, 1994) (Periodical Report) (Abstract)
July 11, 1994... SOURCE: Proceedings of the National Academy of Sciences of the United States of America, May 24, 1994;91(11):4882-4886. According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences of...

TB reversible cause of CD4 drop in HIV-negative patients. (tuberculosis, CD4 lymphocytes)
July 18, 1994... Lymphocyte Counts Tuberculosis (TB) appears to be a reversible cause of CD4 lymphocytopenia in human immunodeficiency virus (HIV)-negative patients, according to a report from a New York City research center. A decrease in the...

Clinton AIDS Czar resigns. (National AIDS Policy Coordinator, Kristine Gebbie)
July 18, 1994... U.S. Government U.S. President Bill Clinton's first National AIDS Policy Coordinator, Kristine Gebbie, who along with the Clinton administration has come under fire for not moving more forcefully to address the disease, resigned July 8,...

French get HIV test royalties.
July 18, 1994... International Hoping to end a years-long dispute over development of an HIV test, American health officials agreed to give more of the patent royalties to France and acknowledged that a French virus was used to invent the test. ...

Identified HIV-1 subtype O viruses for HIV diagnosis.
July 18, 1994... Diagnosis An informal consultation of 22 international experts on the implications of the newly identified HIV-1 subtype O viruses for HIV diagnosis took place on June 9-10, 1994, at the World Health Organization (WHO) headquarters, in...

Symposium in conjunction with AIDS conference. (University of California, Los Angeles symposium on "Treatment of HIV Disease: Advances and Future Challenges", Tenth International Conference on AIDS)
July 18, 1994... Tenth International Conference on AIDS The University of California, Los Angeles (UCLA), AIDS Institute is sponsoring an AIDS symposium, "Treatment of HIV Disease: Advances and Future Challenges," to be held in Yokohama, Japan, August...

Guide for treatment of AIDS and other diseases. (published by the University of Texas Medical Branch at Galveston and the University of California, San Diego)
July 18, 1994... Discovery A discovery that could guide the development of future treatments for AIDS, and the prevention of cancer and some inherited diseases, has been published by a collaborative team of researchers from the University of Texas...

Most people underestimate AIDS risk from "phantom" sex partners.
July 18, 1994... STD Most people seriously underestimate the number of potential AIDS carriers they are exposed to with each additional sexual partner they have, new research suggests. The risk of AIDS can increase exponentially with each new sexual...

Status of Immupath reported as potential AIDS treatment.
July 18, 1994... Treatment HemaCare Corporation, Sherman Oaks, California, reported on the progress of the Phase III Investigational New Drug (IND) application to test Immupath, a potential treatment for HIV/AIDS, submitted to the U.S. Food and Drug...

Round of injections given to AIDS vaccine volunteers.
July 18, 1994... Testing Medics injected 30 volunteers in Bangkok, Thailand, for the second time with an experimental U.S.-made AIDS vaccine. The UBI-1 vaccine, manufactured by United Biomedical Inc., is a protein resembling HIV. It is designed to...

Women still at AIDS risk from unsafe sex. (Caribbean)
July 18, 1994... STD Despite widespread educational programs on the dangers of AIDS and HIV infection, Caribbean women are still unaware of the personal risks, experts in the field say. A study carried out by a top health official of the Caribbean...

Association informs patients of possible HIV exposure. (Ontario Hospital Association, blood transfusion recipients)
July 18, 1994... Program The Ontario Hospital Association (OHA) unveiled details of Canada's first comprehensive campaign to inform patients who received blood between 1978 and 1985, that they may have been exposed to HIV. "Previous efforts have...

Lawmakers approve new Russian AIDS law.
July 18, 1994... Legal Issues The lower house of the Russian Parliament gave preliminary approval to a controversial new AIDS law that proposes compulsory AIDS tests for foreigners and other allegedly high-risk groups. The draft law, which has...

HIV carriers in Indonesia may reach 1.5 million.
July 18, 1994... International The number of Indonesians infected with HIV could reach 1.5 million by 1997 unless serious prevention measures are taken, a senior cabinet minister said. Azwar Anas, the Coordinating Minister for People's Welfare told...

AIDS spreads quickly in India.
July 18, 1994... Control AIDS is racing through India just eight years after the first case was detected. Prostitutes, drug addicts and untested blood supplies are the conduits. More than half the prostitutes in cities such as Bombay have HIV. The...

Eastern AIDS awareness is low. (Nepal)
July 18, 1994... International Like other young Nepalese women lured from their villages and sold to Indian brothels, a woman worked in Bombay, India, for ten years and remained a pauper. Then she fell ill and was thrown out of the brothel. A...

China's AIDS experts call for education.
July 18, 1994... STD China must abandon its prudish attitude toward sex education and start promoting AIDS awareness, a report by the Ministry for Public Health said. Only by promoting education among the entire population can China "keep HIV...

New York to require physicians to give AIDS advice.
July 18, 1994... Legal Lawmakers have reached an agreement on a bill that would make New York the first state to require doctors to provide AIDS counseling and other related services to pregnant women and new mothers. Passage of this counseling bill...

Big increase in senior citizens with AIDS. (Florida)
July 18, 1994... Case Rates Senior citizens are not exempt from sex rules of the 90s, according to the executive director of south Florida's largest provider of housing for AIDS sufferers, who reports an enormous increase in seniors with the disease. ...